Key result
Inhibiting GPCR or ITAM platelet signaling pathways reduces venous thrombosis in mice.
Why the study?
Platelets contribute to venous thrombosis, but the underlying signaling mechanisms distinct from arterial thrombosis are largely unknown.
Does inhibition of GPCR and ITAM receptor signaling reduce venous thrombosis in mice?
Population
Wild-type and transgenic mice
Comparison
Inhibitors of platelet-signaling pathways vs control or single pathway inhibition
Design
Preclinical experimental study
Authors
Loading...
Supports platelet signaling inhibition as a venous thrombosis target; leaves open translation to human disease.
Does inhibition of GPCR and ITAM receptor signaling reduce venous thrombosis in mice?
Venous thrombosis initiation requires platelet activation via both GPCRs and ITAM receptors, and strong inhibition of either pathway reduces venous thrombosis in mice.
Mwiza et al. (2022) studied Venous thrombosis. Inhibition of platelet GPCR and ITAM receptor signaling vs. Control or single pathway inhibition was evaluated on Thrombus weights. Strong inhibition of either GPCR or ITAM platelet signaling pathways reduced venous thrombosis in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: